TABLE 1.
The top 20 most relevant journals in the field of the kynurenine pathway (KP) in mood disorders between 2000 and 2020.
| Rank | Source | Country | 2019 JCR® category (partition) | IF2019 | TP | TC |
|---|---|---|---|---|---|---|
| 1 | Brain, Behavior, and Immunity | United States | Neurosciences (Q1), immunology (Q1), psychiatry (Q1) | 6.633 | 47 | 1,962 |
| 2 | Psychoneuroendocrinology | England | Neurosciences (Q1), psychiatry (Q1), endocrinology and metabolism (Q1) | 4.732 | 24 | 975 |
| 3 | Progress in Neuro-Psychopharmacology and Biological Psychiatry | England | Neurosciences (Q2), psychiatry (Q1), pharmacology and pharmacy (Q1), clinical neurology (Q1) | 4.361 | 19 | 1,064 |
| 4 | Journal of Affective Disorders | Netherlands | Psychiatry (Q1), clinical neurology (Q1) | 3.892 | 18 | 668 |
| 5 | Molecular Psychiatry | England | Neurosciences (Q1), psychiatry (Q1), biochemistry and molecular biology (Q1) | 12.384 | 18 | 2,368 |
| 6 | Journal of Neuroinflammation | England | Neurosciences (Q1), immunology (Q1) | 5.793 | 17 | 1,095 |
| 7 | PLoS One | United States | Multidisciplinary sciences (Q2) | 2.740 | 16 | 400 |
| 8 | Current Pharmaceutical Design | United Arab Emirates | Pharmacology and pharmacy (Q3) | 2.208 | 15 | 621 |
| 9 | Psychiatry Research | Netherlands | Psychiatry (Q3) | 2.118 | 13 | 317 |
| 10 | Frontiers in Psychiatry | Switzerland | Psychiatry (Q2) | 2.849 | 12 | 163 |
| 11 | Journal of Neural Transmission | Austria | Neurosciences (Q2), clinical neurology (Q2) | 3.505 | 12 | 606 |
| 12 | Journal of Neuroscience | United States | Neurosciences (Q1) | 5.674 | 12 | 1,066 |
| 13 | Neuroscience | England | Neurosciences (Q2) | 3.056 | 12 | 752 |
| 14 | Neuroscience and Biobehavioral Reviews | England | Neurosciences (Q1), behavioral sciences (Q1) | 8.329 | 12 | 1,172 |
| 15 | CNS and Neurological Disorders-Drug Targets | Netherlands | Neurosciences (N/A), pharmacology and pharmacy (N/A) | N/A | 11 | 242 |
| 16 | Journal of Psychiatric Research | England | Psychiatry (Q2) | 3.745 | 11 | 1,237 |
| 17 | Neuropsychopharmacology | England | Neurosciences (Q1), psychiatry (Q1), pharmacology and pharmacy (Q1) | 6.751 | 11 | 1,541 |
| 18 | Behavioral Brain Research | Netherlands | Neurosciences (Q3), behavioral sciences (Q2) | 2.977 | 10 | 265 |
| 19 | International Journal of Neuropsychopharmacology | England | Neurosciences (Q2), psychiatry (Q1), pharmacology and pharmacy (Q1), clinical neurology (Q1) | 4.333 | 10 | 298 |
| 20 | Neuropsychiatric disease and Treatment | New Zealand | Psychiatry (Q3), clinical neurology (Q3) | 2.157 | 10 | 188 |
Note. JCR®: journal of citation reports in Web of Science, IF 2019: impact factor in 2019, TP: total publications, TC: total citations, N/A: not available.